EAGLE Crash Lands: AstraZeneca's Imfinzi/Tremelimumab Continues To Disappoint

 
• By Eleanor Malone
Eagle
AstraZeneca's EAGLE has not soared • Source: Shutterstock

More from Immuno-oncology

More from Anticancer